Literature DB >> 2983062

Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.

C J Hillard, R A Harris, A S Bloom.   

Abstract

The effects of four cannabinoids on the physical properties of brain synaptic plasma membranes (SPM), lipid extracts of SPM and phospholipid vesicles were evaluated using fluorescence probes. In vitro, the psychoactive cannabinoids, delta 9-tetrahydrocannabinol (delta 9-THC) and 11-hydroxyl-delta 9-tetrahydrocannabinol (11-OH-delta 9-THC) at concentrations of 1 and 3 microM decreased polarization of the fluorescence emission of 1,6-diphenyl-1,3,5-hexatriene (DPH) in SPM. At the same concentrations, cannabidiol (CBD) and cannabinol, cannabinoids devoid of marijuana-like psychoactivity, had no effect on DPH polarization. The effects of 11-OH-delta 9-THC and CBD on vesicles made from lipids extracted from SPM were identical to their effects on intact SPM. These changes in DPH polarization were not due to changes in fluorescence lifetime and indicate that, at low concentrations, the psychoactive cannabinoids increase the rotational mobility of DPH in the membrane core. In contrast, in SPM-extracted lipids, both 11-OH-delta 9-THC and CBD decreased the mobility of stearic acid with an anthroyloxy label at both the second (2-AS) and twelfth (12-AS) carbon atoms. Studies of DPH polarization in various phosphatidylcholines (PC) demonstrated that the actions of the cannabinoids were dependent on initial bilayer fluidity. 11-OH-delta 9-THC was less effective at decreasing polarization of trimethylammonium DPH (TMA-DPH), a probe of the bilayer surface, than of DPH whereas CBD affected mobility of the two probes equally. Neither CBD nor 11-OH-delta 9-THC altered DPH mobility in phosphatidylethanolamine, phosphatidylserine vesicles. These findings indicate that the psychoactive cannabinoids increase fluidity in the hydrophobic core of brain membranes and support a membrane perturbant hypothesis of the mechanism of delta 9-THC action.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983062

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes.

Authors:  A S Bloom; W S Edgemond; J C Moldvan
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

Review 2.  Efficacy in CB1 receptor-mediated signal transduction.

Authors:  Allyn C Howlett
Journal:  Br J Pharmacol       Date:  2004-08       Impact factor: 8.739

3.  Human pharmacology of 1S and 1R enantiomers of delta-3-tetrahydrocannabinol.

Authors:  L E Hollister; H K Gillespie; R Mechoulam; M Srebnik
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 4.  A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.

Authors:  Matthew J Pava; John J Woodward
Journal:  Alcohol       Date:  2012-03-27       Impact factor: 2.405

5.  Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors.

Authors:  Zhibin Liang; David Soriano-Castell; Devin Kepchia; Brendan M Duggan; Antonio Currais; David Schubert; Pamela Maher
Journal:  Free Radic Biol Med       Date:  2022-01-06       Impact factor: 7.376

6.  Cannabinoids decrease the th17 inflammatory autoimmune phenotype.

Authors:  Ewa Kozela; Ana Juknat; Nathali Kaushansky; Neta Rimmerman; Avraham Ben-Nun; Zvi Vogel
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-28       Impact factor: 4.147

Review 7.  Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation.

Authors:  Kathleen L McCoy
Journal:  Mediators Inflamm       Date:  2016-08-11       Impact factor: 4.711

8.  Cannabidiol Inhibits Multiple Ion Channels in Rabbit Ventricular Cardiomyocytes.

Authors:  Dmytro Isaev; Waheed Shabbir; Ege Y Dinc; Dietrich E Lorke; Georg Petroianu; Murat Oz
Journal:  Front Pharmacol       Date:  2022-02-03       Impact factor: 5.810

Review 9.  From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases.

Authors:  Tommaso Cassano; Rosanna Villani; Lorenzo Pace; Antonio Carbone; Vidyasagar Naik Bukke; Stanislaw Orkisz; Carlo Avolio; Gaetano Serviddio
Journal:  Front Pharmacol       Date:  2020-03-06       Impact factor: 5.810

10.  Adverse effects of Δ9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development.

Authors:  Johannes Beiersdorf; Zsofia Hevesi; Daniela Calvigioni; Jakob Pyszkowski; Roman Romanov; Edit Szodorai; Gert Lubec; Sally Shirran; Catherine H Botting; Siegfried Kasper; Geoffrey W Guy; Roy Gray; Vincenzo Di Marzo; Tibor Harkany; Erik Keimpema
Journal:  JCI Insight       Date:  2020-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.